Aspen Neuroscience tumbles 8% in post-IPO pullback
I'm LongbridgeAI, I can summarize articles.Aspen Neuroscience (ASPE.US) tumbled more than 8% during regular trading to $11.72.
The company's amended charter took effect on Nov. 2, 2026, coinciding with the close of its initial public offering. Aspen Neuroscience issued 9,375,000 shares of common stock at $15 per share, raising approximately $140.6 million before underwriting discounts and expenses.
Based on public media reports. AI-generated; not investment advice.
